Stock listing

TSX:MDNA Medicenna Therapeutics Corp. Stock

Home listing (TSX) of Medicenna Therapeutics Corp.

Follow Medicenna Therapeutics Corp. into a list and get an email when it puts out news.

Share price · TSX:MDNA

$0.39 CAD -0.02 (-4.9%)

Close on Oct 20, 2026

Past 3 months +1.3% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits
Day range
$0.385 – $0.395 CADOct 20, 2026
Volume
53,508 sharesOct 20, 2026
Market cap
$36.00M CADAt the close on Oct 20, 2026 · price × 92.30M shares outstanding
Medicenna Therapeutics Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSX:MDNA · Home$0.39 CAD-0.02 (-4.9%)53,508$0.39$0.395$0.385$0.41Close on Oct 20, 2026
OTC:MDNAF$0.281 USD-0.021 (-6.9%)500$0.281$0.281$0.281$0.302Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · TSX:MDNA · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.39-0.02-4.9%$0.39$0.395$0.38553,508
$0.41-0.04-8.9%$0.45$0.45$0.38596,838
$0.45+0.01+2.3%$0.44$0.45$0.4420,028
$0.440.000.0%$0.445$0.445$0.4410,650
$0.44+0.005+1.1%$0.445$0.445$0.4258,815
$0.4350.000.0%$0.45$0.46$0.43594,356
$0.435-0.01-2.2%$0.435$0.435$0.433,000
$0.445-0.005-1.1%$0.45$0.46$0.4344,700
$0.45+0.015+3.4%$0.435$0.45$0.43523,800
$0.435+0.025+6.1%$0.40$0.47$0.395325,400
$0.41+0.025+6.5%$0.385$0.425$0.38515,000
$0.385-0.005-1.3%$0.40$0.40$0.38531,400
$0.39+0.005+1.3%$0.38$0.39$0.3720,100
$0.385-0.01-2.5%$0.385$0.40$0.3882,500
$0.3950.000.0%$0.39$0.40$0.3954,200
$0.395-0.01-2.5%$0.405$0.405$0.3956,800
$0.4050.000.0%$0.405$0.405$0.4050
$0.4050.000.0%$0.405$0.41$0.4051,500
$0.405-0.005-1.2%$0.40$0.405$0.401,800
$0.41-0.015-3.5%$0.415$0.415$0.4134,300
$0.4250.000.0%$0.425$0.425$0.4251,500
$0.425+0.02+4.9%$0.415$0.43$0.4139,700
$0.405+0.005+1.3%$0.41$0.41$0.3749,700
$0.400.000.0%$0.395$0.40$0.3880,700
$0.40-0.02-4.8%$0.41$0.41$0.4047,300
$0.42+0.005+1.2%$0.43$0.43$0.417,300
$0.415-0.005-1.2%$0.415$0.42$0.4124,900
$0.42-0.01-2.3%$0.43$0.43$0.4229,400
$0.43-0.03-6.5%$0.45$0.45$0.42584,600
$0.46-0.01-2.1%$0.47$0.47$0.4516,300
$0.470.000.0%$0.475$0.475$0.4714,500
$0.47+0.01+2.2%$0.465$0.48$0.46533,800
$0.46-0.01-2.1%$0.46$0.465$0.4561,200
$0.470.000.0%$0.475$0.48$0.4623,100
$0.47-0.005-1.1%$0.48$0.485$0.445127,800
$0.475+0.015+3.3%$0.475$0.48$0.4759,200
$0.46-0.01-2.1%$0.478$0.48$0.4626,100
$0.470.000.0%$0.48$0.49$0.4773,800
$0.47+0.035+8.0%$0.45$0.49$0.44101,500
$0.435+0.025+6.1%$0.415$0.455$0.41536,700
$0.41-0.005-1.2%$0.415$0.415$0.4026,300
$0.4150.000.0%$0.435$0.435$0.40525,700
$0.415-0.02-4.6%$0.43$0.43$0.40152,400
$0.435-0.005-1.1%$0.44$0.44$0.42532,100
$0.44-0.02-4.3%$0.46$0.46$0.4444,900
$0.46+0.06+15.0%$0.41$0.46$0.41125,900
$0.40-0.005-1.2%$0.415$0.435$0.4064,000
$0.405+0.005+1.3%$0.405$0.41$0.4011,500
$0.40+0.005+1.3%$0.40$0.40$0.3957,100
$0.395+0.02+5.3%$0.39$0.395$0.3827,400
$0.375-0.015-3.8%$0.39$0.39$0.37521,400
$0.39+0.01+2.6%$0.40$0.40$0.37541,400
$0.38+0.02+5.6%$0.375$0.395$0.3670,800
$0.360.000.0%$0.365$0.37$0.33549,800
$0.36+0.01+2.9%$0.345$0.365$0.34514,500
$0.350.000.0%$0.355$0.355$0.33579,500
$0.35-0.005-1.4%$0.36$0.36$0.34525,100
$0.355+0.01+2.9%$0.35$0.355$0.3534,100
$0.345-0.005-1.4%$0.36$0.365$0.34575,800
$0.35+0.005+1.4%$0.35$0.355$0.3513,700
$0.345-0.005-1.4%$0.355$0.355$0.3417,100
$0.350.000.0%$0.35$0.355$0.3430,100
$0.350.000.0%$0.355$0.355$0.33530,500
$0.350.000.0%$0.35$0.355$0.34550,000
Ticker
TSX:MDNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TSX
Currency
CAD

What changed lately

Latest news

Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026

Oct 5, 2026

Closed $0.41 (+6.5%) on Oct 5, 2026

Medicenna Announces Results of Annual General and Special Meeting of Shareholders

Oct 1, 2026

Closed $0.385 (-1.3%) on Oct 2, 2026

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Sep 24, 2026

Closed $0.405 (0.0%) on Sep 24, 2026

Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Sep 3, 2026

Closed $0.47 (+2.2%) on Sep 3, 2026

Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences

Aug 14, 2026

Closed $0.46 (+15.0%) on Aug 14, 2026

Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights

Jun 26, 2026

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

Jun 11, 2026

Medicenna's MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

Jun 3, 2026

Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs

May 28, 2026

Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet

May 22, 2026

All Medicenna Therapeutics Corp. news

Decks

Medicenna Therapeutics Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
27 in the last 12 months · 141 in all · newest Oct 5, 2026 · oldest 2017
Decks
5 decks · latest September 2026

Where Medicenna Therapeutics Corp. is listed

ListingExchangeCountryCurrency
TSX:MDNA · Home listing · This pageTSXCanadaCAD
OTC:MDNAFOTCUnited StatesUSD
Cboe Canada:MDNACboe CanadaCanadaCAD

Log in to ask 6ix AI your own questions about Medicenna Therapeutics Corp.